Brokerages Set Nu Skin Enterprises, Inc. (NUS) Target Price at $63.14

Nu Skin Enterprises, Inc. (NYSE:NUS) has earned a consensus rating of “Hold” from the ten ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $63.14.

A number of research analysts have recently commented on the stock. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 price objective for the company in a research report on Saturday, December 30th.

Shares of Nu Skin Enterprises (NYSE:NUS) traded up $1.68 on Tuesday, hitting $69.99. 352,832 shares of the stock were exchanged, compared to its average volume of 337,487. The firm has a market capitalization of $3,690.00, a price-to-earnings ratio of 25.64, a P/E/G ratio of 2.27 and a beta of 1.55. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18. Nu Skin Enterprises has a 1-year low of $47.10 and a 1-year high of $70.27.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.76. The business had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The firm’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.98 earnings per share. equities research analysts predict that Nu Skin Enterprises will post 3.24 earnings per share for the current year.

In related news, Chairman Steven Lund sold 8,977 shares of the company’s stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $70.04, for a total value of $628,749.08. Following the sale, the chairman now owns 4,769 shares of the company’s stock, valued at $334,020.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Ryan S. Napierski sold 11,667 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total transaction of $744,821.28. Following the completion of the sale, the president now directly owns 71,634 shares in the company, valued at approximately $4,573,114.56. The disclosure for this sale can be found here. In the last three months, insiders sold 220,776 shares of company stock worth $14,784,324. 5.20% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of NUS. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Nu Skin Enterprises in the third quarter valued at about $148,000. Dynamic Technology Lab Private Ltd bought a new stake in Nu Skin Enterprises in the third quarter valued at about $219,000. Quantbot Technologies LP bought a new stake in Nu Skin Enterprises in the third quarter valued at about $229,000. Shelton Capital Management bought a new stake in Nu Skin Enterprises in the second quarter valued at about $232,000. Finally, Virtu KCG Holdings LLC bought a new stake in Nu Skin Enterprises during the second quarter worth about $255,000. 77.50% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.chaffeybreeze.com/2018/01/21/brokerages-set-nu-skin-enterprises-inc-nus-target-price-at-63-14.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply